文献速递治疗药物监测与药物基因组学

达托霉素精准给药:3、2、1和0浓度采样策略的比较

Precision Daptomycin Dosing: Comparison of 3-, 2-, 1-, and 0-Concentration Sample Strategies.
PubMed 文献 · Pharmacotherapy · 2025-08-07

本研究纳入210例接受达托霉素治疗的患者,比较3点、2点、1点和0点采样策略估算AUC24的精确性和偏倚。结果显示,仅45.7%患者达到目标AUC24范围666-939 mg·h/L;两点贝叶斯法精确性最高(R2=0.87),单点中点采样与谷浓度采样相关性相似且优于峰浓度采样。

要点

  • 两点贝叶斯法(峰+谷)估算AUC24精确性最高(R2=0.87),偏倚最低。
  • 单点中点采样精确性(R2=0.57)与谷浓度采样(R2=0.55)相似,优于峰浓度采样(R2=0.44)。
  • 仅45.7%患者达到目标AUC24范围666-939 mg·h/L,提示剂量优化需求。

核心结论

  • 中点单点采样可作为传统TDM的实用替代方案,在无法完成全采样时提供较一致的AUC估算。
  • 两点贝叶斯法仍是最精确的策略,支持更广泛地实施个体化达托霉素给药。

研究设计与样本

  • 回顾性分析纳入210例接受达托霉素治疗的成人患者,每例均有至少3个稳态浓度(峰、中点、谷)。
  • 应用已发表的一室群体药动学模型进行贝叶斯估计(Monolix Suite 2024R1),以3点法估算的AUC24为参考,比较不同采样策略的精确性(R2)和平均偏倚。

主要发现

  • 患者平均(范围)年龄66(18-91)岁,体重78(41-140)kg,BMI 27(14-51)kg/m2,男性占60%。
  • 共分析880个达托霉素浓度,平均(范围)剂量9(5-17)mg/kg,平均(范围)AUC24为869(385-1692)mg·h/L。
  • 仅45.7%患者达到目标AUC24范围666-939 mg·h/L。
  • 单点中点采样与AUC24的相关性(R2=0.57)与仅谷浓度(R2=0.55)相似,且精确性高于仅峰浓度(R2=0.44)。
  • 两点贝叶斯法(峰+谷)精确性最高(R2=0.87)且偏倚最低。

临床怎么用

  • 在无法进行完整采样时,可考虑采用中点单点采样估算达托霉素AUC24以指导剂量调整。
  • 条件允许时,优先采用两点贝叶斯法(峰+谷)进行个体化给药,以提高AUC24估算准确性。

局限性

  • 本研究为回顾性分析,结果可能受限于数据来源和模型假设。
  • 样本量有限(210例),且仅使用单一群体药动学模型进行贝叶斯估计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Daptomycin is a once-daily lipopeptide antibiotic with a narrow therapeutic window. As higher doses (8-12 mg/kg) are increasingly used to treat resistant gram-positive infections, achieving therapeutic exposure while minimizing toxicity has become critical. Understanding daptomycin therapeutic drug monitoring (TDM) and what sampling strategy may be most precise and feasible are key to guiding appropriate dosing. The primary objective of this study was to ascertain the precision and bias of a mid-point sample area under the curve over 24-h (AUC24) determination compared to a peak and trough sample AUC24 determination using both simple calculation-based methods and a Bayesian model versus no TDM. METHODS: Adult patients receiving daptomycin with at least three steady-state concentrations (peak, mid-point, trough) were included in this analysis. A previously published one-compartment population pharmacokinetic model was applied using Bayesian estimation (Monolix Suite 2024R1). AUC24 values were estimated using all three concentrations (AUCref), and then re-estimated using individual samples (peak, mid-point, or trough) or paired samples (peak + trough). Performance of each strategy was evaluated using regression analysis with the coefficient of determination for precision (R2) and mean bias. RESULTS: The cohort included 210 patients (60% male) with a mean (range) age of 66 (18-91) years, body weight 78 (41-140) kg, and BMI 27 (14-51) kg/m2. A total of 880 daptomycin concentrations were analyzed in patients receiving a mean (range) daptomycin dose of 9 (5-17) mg/kg. The mean (range) AUC24 was 869 (385-1692) mg·h/L; only 45.7% of patients achieved the target range of 666 to 939 mg·h/L. A single mid-point sample had similar correlation to AUC24 (R2 = 0.57) as trough-only (R2 = 0.55), and greater precision than peak-only (R2 = 0.44). Bayesian estimation with two samples (peak + trough) provided the highest accuracy (R2 = 0.87) and lowest bias. CONCLUSIONS: A mid-interval sampling strategy offers a practical alternative to traditional TDM for daptomycin, enabling more consistent AUC estimation when full sampling is not feasible. A two-sample Bayesian approach remains the most accurate, supporting broader implementation of individualized daptomycin dosing.

来源:Pharmacotherapy,查看原文。版权归原作者所有。

引用

  1. Giuliano S, Pai MP, Angelini J, et al. Precision Daptomycin Dosing: Comparison of 3-, 2-, 1-, and 0-Concentration Sample Strategies. Pharmacotherapy. 2025. PMID: 40772492. doi:10.1002/phar.70045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。